SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
United Community Banks, Inc. (UCBIO) trades at a trailing P/E of 9.1. Trailing earnings yield is 10.98%. PEG 0.32 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (9.1); PEG ≤ 1.0 — Peter Lynch undervalued (0.32); earnings yield beats bond yields (10.98%).
- PEG Ratio 0.32 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 10.98% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 74/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — UCBIO
Valuation Multiples
P/E (TTM)9.1
Forward P/EN/A
PEG Ratio0.32
Forward PEGN/A
P/B Ratio0.00
P/S Ratio2.73
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.62
Book Value / Share$0.00
Revenue / Share$8.75
FCF / Share$0.00
Yields & Fair Value
Earnings Yield10.98%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.40 |
$428.72M |
$100.66M |
23.5% |
| 2017 |
$0.92 |
$463.98M |
$67.82M |
14.6% |
| 2018 |
$2.07 |
$577.72M |
$166.11M |
28.8% |
| 2019 |
$2.31 |
$640.98M |
$185.72M |
29% |
| 2020 |
$1.91 |
$695.6M |
$164.09M |
23.6% |
| 2021 |
$2.97 |
$716.27M |
$269.8M |
37.7% |
| 2022 |
$2.52 |
$928.93M |
$277.47M |
29.9% |
| 2023 |
$1.54 |
$1.29B |
$187.54M |
14.5% |
| 2024 |
$2.04 |
$1.48B |
$252.4M |
17% |
| 2025 |
$2.62 |
$1.06B |
$328.1M |
30.9% |
